Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Yann EchelardDirector | TG TherapeuticsTGTX | Open-market sale | 25/11/24 | 25/11/25 | 5,000 sh | $32.57 | $162,850 | −2.2% |
Sagar LonialDirector | TG TherapeuticsTGTX | Open-market sale | 25/09/11 | 25/09/12 | 20,852 sh | $32.24 | $672,268.48 | −18.1% |
Yann EchelardDirector | TG TherapeuticsTGTX | Open-market sale | 25/06/13 | 25/06/16 | 10,000 sh | $36.94 | $369,400 | −4.2% |
TG TherapeuticsTGTX | Open-market sale | 25/01/03–25/01/06 | 25/01/07 | 21,358 sh2 trades | $29.46avg. | $629,296.86 | −3.1% | |
Laurence N. CharneyDirector | TG TherapeuticsTGTX | Open-market sale | 24/11/11 | 24/11/12 | 25,000 sh | $30.20 | $755,000 | −10.5% |
Sagar LonialDirector | TG TherapeuticsTGTX | Open-market sale | 24/11/11 | 24/11/12 | 5,000 sh | $30.44 | $152,200 | −4.8% |
Yann EchelardDirector | TG TherapeuticsTGTX | Open-market sale | 24/11/05 | 24/11/07 | 20,000 sh | $24.48 | $489,600 | −8.2% |
TG TherapeuticsTGTX | Open-market sale | 24/06/17–24/06/20 | 24/06/20 | 25,933 sh2 trades | $16.69avg. | $432,888.91 | −19.8% | |
Sagar LonialDirector | TG TherapeuticsTGTX | Open-market sale | 24/03/13 | 24/03/15 | 5,000 sh | $15.94 | $79,700 | −4.4% |
Laurence N. CharneyDirector | TG TherapeuticsTGTX | Open-market sale | 24/03/12 | 24/03/13 | 22,000 sh | $15.97 | $351,340 | −9.3% |
Laurence N. CharneyDirector | TG TherapeuticsTGTX | Open-market sale | 24/01/05 | 24/01/08 | 17,500 sh | $19.03 | $333,025 | −6.9% |
TG TherapeuticsTGTX | Open-market sale | 24/01/03 | 24/01/05 | 47,867 sh | $16.91 | $809,430.97 | −7.3% | |
Michael S. WeissCEO and President | TG TherapeuticsTGTX | Open-market buy | 23/08/11 | 23/08/14 | 100,000 sh | $10.13 | $1,013,000 | +0.8% |
Sagar LonialDirector | TG TherapeuticsTGTX | Open-market sale | 23/06/23 | 23/06/26 | 34,854 sh | $23.37 | $814,537.98 | −27.1% |
TG TherapeuticsTGTX | Open-market sale | 23/06/02 | 23/06/05 | 73,647 sh | $26.70 | $1,966,374.9 | −10.1% | |
Yann EchelardDirector | TG TherapeuticsTGTX | Open-market buy | 23/01/06 | 23/01/06 | 9,000 sh | $10.64 | $95,760 | +4.7% |
Laurence N. CharneyDirector | TG TherapeuticsTGTX | Open-market sale | 23/01/04 | 23/01/06 | 30,000 sh | $11.10 | $333,000 | −11.3% |